Sera Prognostics Inc Asset Resilience Ratio
Sera Prognostics Inc asset resilience ratio. Sera Prognostics Inc (SERA) has an Asset Resilience Ratio of 48.48% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SERA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sera Prognostics Inc (2020–2025)
Asset resilience ratio of Sera Prognostics Inc from 2020 to 2025. This chart shows how Sera Prognostics Inc's Asset Resilience Ratio has changed over time. Read SERA total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sera Prognostics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sera Prognostics Inc balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.05 Million | 48.48% |
| Total Liquid Assets | $42.05 Million | 48.48% |
Asset Resilience Insights
- Very High Liquidity: Sera Prognostics Inc maintains exceptional liquid asset reserves at 48.48% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Sera Prognostics Inc Industry Peers by Asset Resilience Ratio
Compare Sera Prognostics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Sera Prognostics Inc Asset Resilience Ratio by Year (2020–2025)
Sera Prognostics Inc asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Sera Prognostics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 34.59% | $35.26 Million | $101.93 Million | -23.55pp |
| 2024-12-31 | 58.14% | $42.19 Million | $72.58 Million | +10.78pp |
| 2023-12-31 | 47.36% | $45.20 Million | $95.44 Million | +1.95pp |
| 2022-12-31 | 45.41% | $52.83 Million | $116.33 Million | +14.00pp |
| 2021-12-31 | 31.41% | $46.18 Million | $147.03 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $14.80 Million | -- |
About Sera Prognostics Inc
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of… Read more